tirzepatide for normal bmi leads to weight reduction in people with obesity due to MC4R deficiency Greater lean-body-mass decline with tirzepatide

The biological functions of stromal cell-derived factors 1 and 1 (SDF-1 and SDF- 1, CXCL12), macrophage-derived chemokine (MDC, CCL22), interferon-inducible T cell -chemoattractant (ITAC, CXCL11), inflammatory protein-10 (IP10, CXCL10), monokine-induced by gamma interferon (MIG, CXCL9), eotaxin (CCL11), granulocyte chemotactic protein 2 (GCP2, CXCL6), and Gro (CXCL2) have been shown to be substrates for proteolytic modification by DPP4

Severe Hypoglycemia was recorded in two of our patients at ADC (AbouSeifien Diabetes Center) treated by Dulaglutide 1.5 weekly with small doses of Meglitides and the hypoglycemic episode lasted for 3 consecutive days

Higher doses may produce longer-lasting appetite control, but they also require careful monitoring

Athletes and active individuals seeking faster recovery between training sessions